Elliot Ehrich Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Elliot Ehrich.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elliot Ehrich. Elliot Ehrich is SVP, R&D & Chief Medical Ofcr in ALKERMES INC ($ALKS) and SVP, R&D & CMO, Alkermes, Inc. in Alkermes plc. ($ALKS).
Latest Insider Trading Transactions of Elliot Ehrich
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 18,000 | 325,890 | 64,000 | |
| Feb 18 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 71.35 | 3,800 | 271,116 | 22,973 | 26.8 K to 23 K (-14.19 %) |
| Feb 18 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 70.74 | 14,200 | 1,004,575 | 26,773 | 41 K to 26.8 K (-34.66 %) |
| Feb 18 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 18,000 | 325,890 | 40,973 | 23 K to 41 K (+78.35 %) |
| Jan 16 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 18,000 | 325,890 | 82,000 | |
| Jan 16 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.60 | 375 | 6,975 | 0 | |
| Jan 16 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 68.02 | 775 | 52,716 | 22,973 | 23.7 K to 23 K (-3.26 %) |
| Jan 16 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 66.96 | 6,400 | 428,532 | 23,748 | 30.1 K to 23.7 K (-21.23 %) |
| Jan 16 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 66.06 | 11,200 | 739,823 | 30,148 | 41.3 K to 30.1 K (-27.09 %) |
| Jan 16 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 18,000 | 325,890 | 41,348 | 23.3 K to 41.3 K (+77.09 %) |
| Jan 16 2015 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.60 | 375 | 6,975 | 23,348 | 23 K to 23.3 K (+1.63 %) |
| Aug 13 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 11.74 | 16,667 | 195,671 | 8,517 | |
| Aug 13 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 41.65 | 16,667 | 694,112 | 22,973 | 39.6 K to 23 K (-42.05 %) |
| Aug 13 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 11.74 | 16,667 | 195,671 | 39,640 | 23 K to 39.6 K (+72.55 %) |
| Jul 11 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 11.74 | 16,667 | 195,671 | 25,184 | |
| Jul 11 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 48.17 | 2,267 | 109,199 | 22,973 | 25.2 K to 23 K (-8.98 %) |
| Jul 11 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 47.29 | 14,400 | 681,025 | 25,240 | 39.6 K to 25.2 K (-36.33 %) |
| Jul 11 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 11.74 | 16,667 | 195,671 | 39,640 | 23 K to 39.6 K (+72.55 %) |
| Jun 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 11.74 | 17,282 | 202,891 | 41,851 | |
| Jun 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 47.10 | 17,282 | 814,044 | 22,973 | 40.3 K to 23 K (-42.93 %) |
| Jun 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 11.74 | 17,282 | 202,891 | 40,255 | 23 K to 40.3 K (+75.23 %) |
| Jun 11 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 11.74 | 16,667 | 195,671 | 59,133 | |
| Jun 11 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 48.15 | 16,667 | 802,563 | 22,973 | 39.6 K to 23 K (-42.05 %) |
| Jun 11 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 11.74 | 16,667 | 195,671 | 39,640 | 23 K to 39.6 K (+72.55 %) |
| May 30 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| May 30 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 45.74 | 1,769 | 80,914 | 22,973 | 24.7 K to 23 K (-7.15 %) |
| May 30 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 24,742 | 21 K to 24.7 K (+17.86 %) |
| May 23 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 44.49 | 2,378 | 105,806 | 20,992 | 23.4 K to 21 K (-10.18 %) |
| May 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 4,500 | 0 | 9,000 | |
| May 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 3,750 | |
| May 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 44.48 | 2,122 | 94,387 | 23,370 | 25.5 K to 23.4 K (-8.32 %) |
| May 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 4,500 | 0 | 25,492 | 21 K to 25.5 K (+21.44 %) |
| May 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 44.00 | 1,981 | 87,160 | 20,992 | 23 K to 21 K (-8.62 %) |
| May 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 43.98 | 1,769 | 77,801 | 22,973 | 24.7 K to 23 K (-7.15 %) |
| May 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 24,742 | 21 K to 24.7 K (+17.86 %) |
| May 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 4,175 | 0 | 0 | |
| May 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 43.55 | 2,206 | 96,065 | 20,992 | 23.2 K to 21 K (-9.51 %) |
| May 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 43.59 | 1,969 | 85,829 | 23,198 | 25.2 K to 23.2 K (-7.82 %) |
| May 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 4,175 | 0 | 25,167 | 21 K to 25.2 K (+19.89 %) |
| May 06 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 20.79 | 2,000 | 41,580 | 2,687 | |
| May 06 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.60 | 5,376 | 99,994 | 0 | |
| May 06 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 47.75 | 870 | 41,543 | 20,992 | 21.9 K to 21 K (-3.98 %) |
| May 06 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 20.79 | 2,000 | 41,580 | 21,862 | 19.9 K to 21.9 K (+10.07 %) |
| May 06 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 47.75 | 2,093 | 99,941 | 19,862 | 22 K to 19.9 K (-9.53 %) |
| May 06 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.60 | 5,376 | 99,994 | 21,955 | 16.6 K to 22 K (+32.43 %) |
| Mar 05 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Mar 05 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | A | 47.16 | 65,000 | 3,065,400 | 65,000 | |
| Feb 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 20.79 | 7,718 | 160,457 | 0 | |
| Feb 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 52.45 | 7,718 | 404,794 | 16,579 | 24.3 K to 16.6 K (-31.77 %) |
| Feb 20 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 20.79 | 7,718 | 160,457 | 24,297 | 16.6 K to 24.3 K (+46.55 %) |
| Jan 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 20.79 | 6,345 | 131,913 | 7,718 | |
| Jan 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.60 | 1,373 | 25,538 | 375 | |
| Jan 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 48.61 | 7,718 | 375,161 | 16,579 | 24.3 K to 16.6 K (-31.77 %) |
| Jan 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 20.79 | 6,345 | 131,913 | 24,297 | 18 K to 24.3 K (+35.34 %) |
| Jan 22 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.60 | 1,373 | 25,538 | 17,952 | 16.6 K to 18 K (+8.28 %) |
| Jan 17 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 9.21 | 10,000 | 92,100 | 0 | |
| Jan 17 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 8.55 | 4,555 | 38,945 | 11,698 | |
| Jan 17 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 47.35 | 14,555 | 689,115 | 16,579 | 31.1 K to 16.6 K (-46.75 %) |
| Jan 17 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 9.21 | 10,000 | 92,100 | 31,134 | 21.1 K to 31.1 K (+47.32 %) |
| Jan 17 2014 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 8.55 | 4,555 | 38,945 | 21,134 | 16.6 K to 21.1 K (+27.47 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.60 | 7,718 | 143,555 | 1,748 | |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 12.29 | 8,136 | 99,991 | 0 | |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.13 | 15,000 | 211,950 | 0 | |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 15.95 | 6,269 | 99,991 | 0 | |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 15.95 | 23,731 | 378,509 | 0 | |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 38.84 | 7,718 | 299,770 | 16,579 | 24.3 K to 16.6 K (-31.77 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.60 | 7,718 | 143,555 | 24,297 | 16.6 K to 24.3 K (+46.55 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 39.61 | 7,936 | 314,349 | 16,579 | 24.5 K to 16.6 K (-32.37 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 38.69 | 45,200 | 1,748,964 | 24,515 | 69.7 K to 24.5 K (-64.84 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 12.29 | 8,136 | 99,991 | 69,715 | 61.6 K to 69.7 K (+13.21 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.13 | 15,000 | 211,950 | 61,579 | 46.6 K to 61.6 K (+32.20 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 15.95 | 6,269 | 99,991 | 46,579 | 40.3 K to 46.6 K (+15.55 %) |
| Dec 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 15.95 | 23,731 | 378,509 | 40,310 | 16.6 K to 40.3 K (+143.14 %) |
| Nov 19 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| Nov 19 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.60 | 7,718 | 143,555 | 9,466 | |
| Nov 19 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 36.65 | 2,639 | 96,711 | 16,579 | 19.2 K to 16.6 K (-13.73 %) |
| Nov 19 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 36.89 | 2,361 | 87,097 | 19,218 | 21.6 K to 19.2 K (-10.94 %) |
| Nov 19 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 5,000 | 0 | 21,579 | 16.6 K to 21.6 K (+30.16 %) |
| Nov 19 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 38.00 | 7,718 | 293,247 | 16,579 | 24.3 K to 16.6 K (-31.77 %) |
| Nov 19 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.60 | 7,718 | 143,555 | 24,297 | 16.6 K to 24.3 K (+46.55 %) |
| Oct 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.60 | 7,718 | 143,555 | 17,184 | |
| Oct 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 35.37 | 7,718 | 272,996 | 16,579 | 24.3 K to 16.6 K (-31.77 %) |
| Oct 18 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.60 | 7,718 | 143,555 | 24,297 | 16.6 K to 24.3 K (+46.55 %) |
| Sep 20 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 18.60 | 7,722 | 143,629 | 24,902 | |
| Sep 20 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 34.80 | 7,722 | 268,720 | 16,579 | 24.3 K to 16.6 K (-31.78 %) |
| Sep 20 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 18.60 | 7,722 | 143,629 | 24,301 | 16.6 K to 24.3 K (+46.58 %) |
| Jun 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 12.29 | 36,864 | 453,059 | 8,136 | |
| Jun 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 30.19 | 36,864 | 1,112,858 | 16,579 | 53.4 K to 16.6 K (-68.98 %) |
| Jun 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 12.29 | 36,864 | 453,059 | 53,443 | 16.6 K to 53.4 K (+222.35 %) |
| May 29 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| May 29 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | A | 33.72 | 80,000 | 2,697,600 | 80,000 | |
| May 29 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 2,125 | 0 | 0 | |
| May 29 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 33.58 | 1,122 | 37,682 | 16,579 | 17.7 K to 16.6 K (-6.34 %) |
| May 29 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 32.84 | 1,003 | 32,939 | 17,701 | 18.7 K to 17.7 K (-5.36 %) |
| May 29 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 2,125 | 0 | 18,704 | 16.6 K to 18.7 K (+12.82 %) |
| May 22 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 4,500 | 0 | 13,500 | |
| May 22 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 32.50 | 2,375 | 77,197 | 16,579 | 19 K to 16.6 K (-12.53 %) |
| May 22 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 31.98 | 2,125 | 67,958 | 18,954 | 21.1 K to 19 K (-10.08 %) |
| May 22 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 4,500 | 0 | 21,079 | 16.6 K to 21.1 K (+27.14 %) |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 7,500 | |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 4,175 | 0 | 4,175 | |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 30.56 | 1,980 | 60,509 | 16,579 | 18.6 K to 16.6 K (-10.67 %) |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 31.04 | 1,770 | 54,941 | 18,559 | 20.3 K to 18.6 K (-8.71 %) |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 20,329 | 16.6 K to 20.3 K (+22.62 %) |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 31.59 | 2,204 | 69,624 | 16,579 | 18.8 K to 16.6 K (-11.73 %) |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Payment of Exercise | F | 31.69 | 1,971 | 62,461 | 18,783 | 20.8 K to 18.8 K (-9.50 %) |
| May 21 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 4,175 | 0 | 20,754 | 16.6 K to 20.8 K (+25.18 %) |
| Mar 11 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 9.21 | 30,000 | 276,300 | 10,000 | |
| Mar 11 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 22.52 | 30,000 | 675,480 | 16,579 | 46.6 K to 16.6 K (-64.41 %) |
| Mar 11 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 9.21 | 30,000 | 276,300 | 46,579 | 16.6 K to 46.6 K (+180.95 %) |
| Feb 01 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.38 | 6,323 | 90,925 | 0 | |
| Feb 01 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.38 | 177 | 2,545 | 0 | |
| Feb 01 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 23.00 | 6,500 | 149,500 | 16,579 | 23.1 K to 16.6 K (-28.16 %) |
| Feb 01 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.38 | 6,323 | 90,925 | 23,079 | 16.8 K to 23.1 K (+37.74 %) |
| Feb 01 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.38 | 177 | 2,545 | 16,756 | 16.6 K to 16.8 K (+1.07 %) |
| Jan 17 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 11.74 | 40,000 | 469,600 | 75,800 | |
| Jan 17 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 8.55 | 48,747 | 416,787 | 16,253 | |
| Jan 17 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 22.09 | 11,301 | 249,629 | 16,579 | 27.9 K to 16.6 K (-40.53 %) |
| Jan 17 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 22.09 | 88,747 | 1,960,341 | 27,880 | 116.6 K to 27.9 K (-76.09 %) |
| Jan 17 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 11.47 | 40,000 | 458,800 | 116,627 | 76.6 K to 116.6 K (+52.20 %) |
| Jan 17 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 8.55 | 48,747 | 416,787 | 76,627 | 27.9 K to 76.6 K (+174.85 %) |
| Jan 10 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.38 | 7,000 | 100,660 | 6,323 | |
| Jan 10 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 22.00 | 7,000 | 154,000 | 27,880 | 34.9 K to 27.9 K (-20.07 %) |
| Jan 10 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.38 | 7,000 | 100,660 | 34,880 | 27.9 K to 34.9 K (+25.11 %) |
| Jan 08 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.38 | 7,000 | 100,660 | 13,323 | |
| Jan 08 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 21.00 | 7,000 | 147,000 | 27,880 | 34.9 K to 27.9 K (-20.07 %) |
| Jan 08 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.38 | 7,000 | 100,660 | 34,880 | 27.9 K to 34.9 K (+25.11 %) |
| Jan 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.90 | 70,980 | 1,057,602 | 0 | |
| Jan 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.90 | 520 | 7,748 | 0 | |
| Jan 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 20.00 | 71,500 | 1,430,007 | 27,880 | 99.4 K to 27.9 K (-71.95 %) |
| Jan 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.90 | 70,980 | 1,057,602 | 99,380 | 28.4 K to 99.4 K (+249.93 %) |
| Jan 04 2013 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.90 | 520 | 7,748 | 28,400 | 27.9 K to 28.4 K (+1.87 %) |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 12.30 | 7,030 | 86,469 | 0 | |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 12.30 | 15,470 | 190,281 | 7,030 | |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 12.30 | 5,634 | 69,298 | 0 | |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 19.50 | 7,030 | 137,085 | 27,880 | 34.9 K to 27.9 K (-20.14 %) |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 12.30 | 7,030 | 86,469 | 34,910 | 27.9 K to 34.9 K (+25.22 %) |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 19.50 | 15,470 | 301,670 | 27,880 | 43.4 K to 27.9 K (-35.69 %) |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 12.30 | 15,470 | 190,281 | 43,350 | 27.9 K to 43.4 K (+55.49 %) |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 19.50 | 5,634 | 109,865 | 27,880 | 33.5 K to 27.9 K (-16.81 %) |
| Dec 21 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 12.30 | 5,634 | 69,298 | 33,514 | 27.9 K to 33.5 K (+20.21 %) |
| Dec 13 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 12.30 | 1,866 | 22,952 | 5,634 | |
| Dec 13 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 19.50 | 1,866 | 36,396 | 27,880 | 29.7 K to 27.9 K (-6.27 %) |
| Dec 13 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 12.30 | 1,866 | 22,952 | 29,746 | 27.9 K to 29.7 K (+6.69 %) |
| Dec 11 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.57 | 796 | 11,598 | 0 | |
| Dec 11 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.57 | 24,473 | 356,572 | 796 | |
| Dec 11 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Option Exercise | M | 14.57 | 1,731 | 25,221 | 0 | |
| Dec 11 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 19.18 | 796 | 15,267 | 27,880 | 28.7 K to 27.9 K (-2.78 %) |
| Dec 11 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Buy | M | 14.57 | 796 | 11,598 | 28,676 | 27.9 K to 28.7 K (+2.86 %) |
| Dec 11 2012 | ALKS | Alkermes plc. | Ehrich Elliot | SVP, R&D & CMO, Alk ... | Sell | S | 19.00 | 24,473 | 464,987 | 27,880 | 52.4 K to 27.9 K (-46.75 %) |